Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shailender Bhatia

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Cancer|August 18, 2016
Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!Shailender Bhatia, Kim Margolin
JAMA|April 20, 2016
PD-1 Blockade in Melanoma: A Promising Start, but a Long Way to GoShailender Bhatia, John A Thompson
Advances in Therapy|January 28, 2009
Temsirolimus in patients with advanced renal cell carcinoma: an overviewShailender Bhatia, John A Thompson
Journal of the National Comprehensive Cancer Network : JNCCN|June 13, 2018
Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's GuideKelly G Paulson, Shailender Bhatia
Lancet (London, England)|July 19, 2014
Melanoma: immune checkpoint blockade story gets betterShailender Bhatia, John A Thompson
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
Systemic therapy for metastatic melanoma in 2012: dawn of a new eraShailender Bhatia, John A Thompson
Current Oncology Reports|September 29, 2011
Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancerShailender Bhatia, Olga Afanasiev, Paul Nghiem
JAAD Case Reports|July 15, 2025
Programmed cell death 1 blockade in the setting of severe ocular sarcoidosis: Cancer immunotherapy in a patient with autoimmunityCharlotte Read, Shailender Bhatia, Mariam Totonchy
Journal of the National Cancer Institute|April 20, 2017
ResponseShailender Bhatia, Barry E Storer, Paul Nghiem
Cancers|April 30, 2021
Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel TherapiesFrederique St-Pierre, Shailender Bhatia, Sunandana Chandra
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Cancer|August 18, 2016
Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!Shailender Bhatia, Kim Margolin
JAMA|April 20, 2016
PD-1 Blockade in Melanoma: A Promising Start, but a Long Way to GoShailender Bhatia, John A Thompson
Advances in Therapy|January 28, 2009
Temsirolimus in patients with advanced renal cell carcinoma: an overviewShailender Bhatia, John A Thompson
Journal of the National Comprehensive Cancer Network : JNCCN|June 13, 2018
Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's GuideKelly G Paulson, Shailender Bhatia
Lancet (London, England)|July 19, 2014
Melanoma: immune checkpoint blockade story gets betterShailender Bhatia, John A Thompson
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
Systemic therapy for metastatic melanoma in 2012: dawn of a new eraShailender Bhatia, John A Thompson
Current Oncology Reports|September 29, 2011
Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancerShailender Bhatia, Olga Afanasiev, Paul Nghiem
JAAD Case Reports|July 15, 2025
Programmed cell death 1 blockade in the setting of severe ocular sarcoidosis: Cancer immunotherapy in a patient with autoimmunityCharlotte Read, Shailender Bhatia, Mariam Totonchy
Journal of the National Cancer Institute|April 20, 2017
ResponseShailender Bhatia, Barry E Storer, Paul Nghiem
Cancers|April 30, 2021
Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel TherapiesFrederique St-Pierre, Shailender Bhatia, Sunandana Chandra
Pageof 13